Barclays boss reveals cancer diagnosis but will continue to manage bank
CS Venkatakrishnan told staff in a letter that he will receive treatment at a cancer centre in New York which is likely to last 12 to 16 weeks.
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Banking giant Barclays has revealed its chief executive CS Venkatakrishnan is undergoing treatment after being diagnosed with non-Hodgkin lymphoma.
Mr Venkatakrishnan, known as Venkat, told staff in a letter that he will receive treatment at a cancer centre in New York which is likely to last 12 to 16 weeks.
He said the lender will run normally during this time and he will still be “actively engaged in managing it”.
He wrote in the letter: “I am writing to inform you that I have been diagnosed with non-Hodgkin lymphoma. The good news is that the matter has been detected early, with scans and biopsies confirming it to be very localised.
I am very confident that we will continue, with your help, to serve our customers and clients well, and produce strong operating performance for our shareholders
“The doctors have advised that my prognosis is excellent, and my condition is curable with their prescribed regimen.”
The CEO said he will have to work from home for some periods and will not be able to travel.
Non-Hodgkin lymphoma is a type of cancer that develops in the lymphatic system, and most cases are considered very treatable, according to the NHS.
Mr Venkatakrishnan said Barclays’ senior management team will be well-equipped to help lead the business while he undergoes treatment.
He added: “We have a highly capable and seasoned executive committee, supported by a talented senior management team.
“I am very confident that we will continue, with your help, to serve our customers and clients well, and produce strong operating performance for our shareholders.
“I am deeply appreciative, and very proud, of your support and extraordinary efforts in these volatile times.”
Mr Venkatakrishnan took on the chief executive role a year ago, having previously been head of global markets.
He succeeded Jes Staley, who stepped down suddenly after an investigation by the Financial Conduct Authority (FCA) into his links to the late convicted sex offender Jeffrey Epstein.
Mr Staley also ran into trouble with the FCA a year after becoming Barclays’ boss, when he was investigated over an attempt to identify a whistleblower.
His pay was docked as a result of his conduct which contravened the lender’s whistleblowing programme.